For example, a study in The New England Journal of Medicine (2022) found that non-diabetic adults using semaglutide lost an average of 14.9% of their body weight in 68 weeks more than with diet and exercise alone
Melanotan-1 (MT-1) is a synthetic peptide utilized in laboratory research to investigate melanocortin receptor activity, pigmentation pathways, and related cellular signaling mechanisms
These medications also slow gastric emptying, which could potentially affect bowel function, though no direct link to diverticulitis flare-ups has been established
Lactic acidosis can be fatal if untreated, but stopping metformin may reverse symptoms
GLP-1 medications for weight loss (with and without diabetes) While GLP-1 medications were originally developed to treat type 2 diabetes, it has become clear that their effects on appetite regulation and satiety can lead to substantial weight loss even in people who do not have diabetes